Eli Lilly and Company LLY
1,429.41 USD +20.03 (+1.42%)
Nov 4, 2026, 12:29 PM EST
1,401.59 Day range 1,445.96
851.21 52-week range 1,429.27
- YTD
- +33.01%
- 1 year
- +57.62%
Financial health
Altman Z-Score
9.48 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 2
- P/B 1
Valuation
P/E 46.6×
FY 2016 5y median 55.7× FY 2025
P/S 14.8×
FY 2016 5y median 14.8× FY 2025
P/B 36.4×
FY 2016 5y median 36.4× FY 2025
P/FCF 108×
FY 2016 5y median 75.6× FY 2025
EV/EBITDA 31.6×
FY 2016 5y median 38.6× FY 2025
EV/Sales 15.3×
FY 2016 5y median 15.3× FY 2025
FCF Yield 0.9%
FY 2016 5y median 0.9% FY 2025
Profitability
Gross Margin 83.0%
FY 2016 5y median 79.2% FY 2025
Operating Margin 45.6%
FY 2016 5y median 31.6% FY 2025
Net Margin 31.7%
FY 2016 5y median 21.9% FY 2025
ROE 77.8%
FY 2016 5y median 62.2% FY 2025
ROIC 30.2%
FY 2016 5y median 23.5% FY 2025
ROA 18.4%
FY 2016 5y median 12.6% FY 2025
Growth (YoY)
Revenue 44.7%
FY 2016 FY 2025
Operating Income 74.3%
FY 2016 FY 2025
EPS (diluted) 96.0%
FY 2016 FY 2025
Free Cash Flow 138.6%
FY 2016 FY 2025
Financial Health
Current Ratio 1.6×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 1.2×
FY 2016 5y median 0.9× FY 2025
Debt / Equity 1.6×
FY 2016 5y median 1.9× FY 2025
Net Debt / EBITDA 1.1×
FY 2016 5y median 1.6× FY 2025
Interest Coverage 37.3×
FY 2016 5y median 23.3× FY 2025
Dividends
Dividend Yield 0.6%
FY 2016 5y median 0.8% FY 2025
Payout Ratio 26.1%
FY 2016 5y median 55.3% FY 2025
Annual · latest fiscal year ends 2025-12-31
